InChI=1S/C33H37N5O5/c1- 32(35- 29(39) 21- 15- 23- 22- 10- 6- 11- 24- 28(22) 20(17- 34- 24) 16- 25(23) 36(2) 18- 21) 31(41) 38- 26(14- 19- 8- 4- 3- 5- 9- 19) 30(40) 37- 13- 7- 12- 27(37) 33(38,42) 43- 32/h3- 6,8- 11,17,21,23,25- 27,34,42H,7,12- 16,18H2,1- 2H3,(H,35,39) /t21- ,23- ,25- ,26+,27+,32- ,33+/m1/s1 |
LUZRJRNZXALNLM-JGRZULCMSA-N |
[H] [C@@] 12Cc3c[nH] c4cccc(c34) [C@@] 1([H] ) C[C@H] (CN2C) C(=O) N[C@] 1(C) O[C@] 2(O) N([C@@H] (Cc3ccccc3) C(=O) N3CCC[C@@] 23[H] ) C1=O |
|
serotonergic agonist
An agent that has an affinity for serotonin receptors and is able to mimic the effects of serotonin by stimulating the physiologic activity at the cell receptors. Serotonin agonists are used as antidepressants, anxiolytics, and in the treatment of migraine disorders.
non-narcotic analgesic
A drug that has principally analgesic, antipyretic and anti-inflammatory actions. Non-narcotic analgesics do not bind to opioid receptors.
dopamine agonist
A drug that binds to and activates dopamine receptors.
sympatholytic agent
Any compound which inhibits the postganglionic functioning of the sympathetic nervous system (SNS).
metabolite
Any intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.
(via alkaloid )
|
|
serotonergic agonist
An agent that has an affinity for serotonin receptors and is able to mimic the effects of serotonin by stimulating the physiologic activity at the cell receptors. Serotonin agonists are used as antidepressants, anxiolytics, and in the treatment of migraine disorders.
non-narcotic analgesic
A drug that has principally analgesic, antipyretic and anti-inflammatory actions. Non-narcotic analgesics do not bind to opioid receptors.
vasoconstrictor agent
Drug used to cause constriction of the blood vessels.
dopamine agonist
A drug that binds to and activates dopamine receptors.
sympatholytic agent
Any compound which inhibits the postganglionic functioning of the sympathetic nervous system (SNS).
|
|
View more via ChEBI Ontology
(10αH)-5'α-benzyl-12'-hydroxy-2'-methyl-3',6',18-trioxo-9,10-dihydroergotaman
|
dihidroergotamina
|
ChemIDplus
|
dihydroergotamine
|
KEGG DRUG
|
dihydroergotaminum
|
ChemIDplus
|
5'-benzyl-12'-hydroxy-2'-methyl-3',6',18-trioxo-9,10-dihydroergotaman
|
NIST Chemistry WebBook
|
9,10-dihydro-12'-hydroxy-2'-methyl-5'-(phenylmethyl)ergotoman-3',6',18-trione
|
NIST Chemistry WebBook
|
9,10-dihydroergotamine
|
ChemIDplus
|
Dihydroergotamine
|
KEGG COMPOUND
|
511-12-6
|
CAS Registry Number
|
KEGG COMPOUND
|
511-12-6
|
CAS Registry Number
|
ChemIDplus
|
511-12-6
|
CAS Registry Number
|
NIST Chemistry WebBook
|
78887
|
Beilstein Registry Number
|
Beilstein
|
10954953
|
PubMed citation
|
Europe PMC
|
20132337
|
PubMed citation
|
Europe PMC
|
8145914
|
PubMed citation
|
Europe PMC
|
|